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Abstract
Background: This research was carried out to develop a reliable monoclonal antibody (MoAb)-based sandwich
enzyme linked immunosorbent assay (ELISA) for the diagnosis of active Fasciola gigantica infection in both serum
and stool for comparative purposes.
Methods: From a panel of MoAbs raised against F. gigantica excretory/secretory antigens (ES Ags), a pair (12B/
11D/3F and 10A/9D/10G) was chosen due to its high reactivity and strict specificity to F. gigantica antigen by
indirect ELISA.
Results: The two MoAbs were of the IgG1 and IgG2a subclasses, respectively. Using SDS-PAGE and EITB, the
selected MoAbs recognized 83, 64, 45 and 26 kDa bands of ES Ags. The lower detection limit of ELISA assay was 3
ng/ml. In stool, the sensitivity, specificity and diagnostic efficacy of ELISA was 96%, 98.2 and 97.1%; while in serum
they were 94%, 94.6% and 94.3%, respectively. Moreover, a positive correlation was found between ova count in
stool of F. gigantica infected patients and the OD readings of ELISA in both stool and serum samples (r = 0.730, p
< 0.01 and r = 0.608; p < 0.01, respectively).
Conclusions: These data showed that the use of MoAb-based sandwich ELISA for the detection of F. gigantica
coproantigens in stool specimens was superior to serum samples; it provides a highly efficient, non-invasive
technique for the diagnosis of active F. gigantica infection.
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Background
Fasciola hepatica and F. gigantica are two trematode
species which have an important impact on public
health due to the infections they cause in humans and
livestock. F. hepatica has a cosmopolitan distribution,
mainly in temperate zones, while F. gigantica is found in
tropical regions of Africa and Asia [1-3]. Although the
majority of cases are attributed to F. hepatica,h u m a n
infections with F. gigantica are also present in many
countries [4-6]. In the Nile Delta of Egypt, beside the
two species, a third intermediate form of Fasciola sp.
has been identified [3] using molecular approaches [7].
Parasitological diagnosis of human fascioliasis is often
unreliable and has low sensitivity, as parasite eggs are
not found during the pre-patent period and shedding of
parasitic eggs is intermittent [8-10]. Moreover, Fasciola
eggs may be found in the stools of uninfected persons
who have eaten raw infected liver leading to false posi-
tive diagnosis [11]. Alternatively, detection of circulating
Fasciola antigen in both serum and stool was found to
be more sensitive and specific [12]. The majority of
methods based on antigen detection are applied to F.
hepatica infection, but only few are applied to F. gigan-
tica infection [13-15].
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cient MoAb-based sandwich ELISA to diagnose active F.
gigantica infection by detecting excretory/secretory anti-
gens (ES Ags) in both serum and stool samples of
infected patients for comparative purposes.
Methods
Study Population
Patients admitted to Gastroenterology and Hepatology
Department, Theodor Bilharz Research Institute
(TBRI), who complained of abdominal pain, loss of
body weight, dyspepsia, fever and diarrhea were sub-
jected to parasitological stool examination on three
consecutive days using merthiolate-iodine-formalde-
hyde concentration method [16]. The number of eggs
per gram stool was determined by the modified Kato-
thick smear technique [17]. Three groups were used;
F. gigantica infected group where patients had the
characteristic large operculated Fasciola eggs in their
stool samples with no evidence of other parasitic
infections (n = 50). Other parasites group (n = 60)
included S. mansoni (n = 20), S. hematobium (n = 20)
and Hymenolepis nana (n = 20). Control group (n =
30) were age- and sex-matched parasite-free healthy
individuals.
Stool Elute Preparation and Serum Samples Collection
Aqueous elutes of a portion of each stool specimen were
prepared by adding approximately 3 parts of 0.01 M
phosphate-buffered saline (PBS), pH 7.2, containing
0.05% Tween 20 (PBS/T) to 1 part of stool in a centri-
fuge tube [18]. The mixture was homogenized and then
c e n t r i f u g e da t9 0 0×g for 5 min. The supernatant was
aspirated and stored at -80°C until use.
Whole blood was collected from each subject and cen-
trifuged at 760 × g at 4°C for 10 minutes and the
obtained serum samples were stored at -80°C until use.
Fasciola Excretory/Secretory (ES) Antigens
Livers of infected cattle were obtained from a local abat-
toir at Giza District, Egypt. Live intact F. gigantica adult
worms were collected from the bile ducts and thor-
oughly washed at room temperature with 0.9% sodium
chloride. The worms were individually incubated at 37°
C in 5 ml RPMI 1640 medium, pH 7.4, supplemented
with 100 U of penicillin and 100 μg of streptomycin per
ml medium (Sigma Chemicals, St. Louis, USA). Follow-
ing 24 h incubation, the medium was centrifuged at
1500 × g for 10 min at 4°C. The supernatants containing
the ES Ags were aspirated [19] and filtered using filter
paper No. 1 and 0.22 mm filter membrane (Millipore,
Bedford, MA). The protein content was determined
using Bio-Rad assay kit. Supernatants were stored at
-20°C until use.
Development of MoAbs against ES Ags
BALB/c mice were immunized with F. gigantica ES Ags
[20]. Immune splenocytes were fused with non-secreting
murine myeloma cells (P3 × 63 Ag. 8) in the presence
of 43% polyethylene glycol (Sigma) [21]. Hybridomas
were screened for anti-Fasciola antibodies by ELISA,
and highly reactive hybrids were cloned by limiting dilu-
tion using a splenocyte feeder layer. Specificity was
determined by indirect ELISA [22] against S. mansoni
SEA and E. granulosus antigens. MoAbs showing no-
cross reactivity with other parasites were selected.
Hybridoma cells were injected intraperitoneally into
BALB/c mice for large-scale production of MoAbs.
Isotypic Analysis of MoAbs
Determination of MoAb isotype was done by indirect
ELISA using ELISA plates coated with 20 μg/ml of F.
gigantica ES Ags and a panel of goat anti-mouse peroxi-
dase-conjugated immunoglobulins (IgM, IgG, IgG1,
IgG2a, IgG2b, IgG3 and IgA, Sigma).
Characterization of Target Antigen
Sodium dodecylsulphate-polyacrilamide gel electrophor-
esis (SDS-PAGE) and Immunoblot was carried out as
described by Laemmli [23]. F. gigantica ES antigens was
fractionated on 12.5% SDS-PAGE and either stained
with Commassie brilliant blue 0.05% or transferred into
nitrocellulose membrane and probed with peroxidase-
conjugated IgG MoAb [24,25]. The chemical nature of
MoAb-recognized epitopes was defined by testing the
reactivity of target antigens by indirect ELISA before
and after 20 mM sodium periodate treatment [26].
Purification and Conjugation of MoAbs
Selected MoAbs of IgG class were purified by ammo-
nium sulfate precipitation, dialyzed against an excess of
PBS and passed through a prepacked Mono-Q-HR 5/5
column (ion exchange chromatography) [27]. The anti-
gen detecting MoAb was conjugated to horseradish per-
oxidase (type VI; Sigma) [28].
Detection of circulating Fasciola antigen (CFA) in both
serum and stool by MoAb-based sandwich ELISA
The following sandwich-ELISA was adopted using a pair
of MoAbs against ES Ags, 12B/11D/3F as antigen cap-
turing and 10A/9D/10G as antigen detecting antibody.
The optimal dilutions of MoAbs were determined by a
checkerboard titration using a negative- and positive-
control serum and stool samples in each plate. For each
step, 100 μl/well was added unless mentioned otherwise.
Polystyrene microtiter plates (Thomas Scientific, USA)
were sensitized overnight at room temperature with
purified 12B/11D/3F MoAb (5 μg/ml of 0.1 M carbonate
buffer, pH 9.6). The plates were thoroughly washed with
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with 200 μl/well of 2.5% fetal calf serum (Sigma) diluted
in PBS/T, pH 7.4. After 2 h incubation at 37°C, the
plates were emptied by suction. Undiluted serum and
stool elutes were added (undiluted) and the plates were
incubated for 1 h at 37°C. After thorough washing as
described above, peroxidase-conjugated 10A/9D/10G
MoAb (10 μg/ml of PBS/T) was added. The plates were
incubated for 1 h at 37°C and washed with PBS/T. The
substrate O-phenylenediamine dihydrochloride (Sigma)
was added and the plates were incubated for 30 minutes
in the dark at room temperature. The enzyme reaction
was stopped with 50 μl/well of 8 N H2SO4.T h ea b s o r -
bance at 492 nm wavelength (A492) of the plates was
read using a microplate ELISA reader (Bio-Rad, Rich-
mond CA, USA).
Statistical analysis
Data were expressed as mean ± standard deviation.
Standard diagnostic indices including sensitivity, specifi-
city and diagnostic efficacy were calculated as described
by Galen [29]. Correlations between different parameters
were performed using Pearson correlation coefficient. P
value greater than 0.05 was considered not significant
and less than 0.01 was considered highly significant.
SPSS computer program (version 12 windows) was used
for data analysis.
Ethical considerations
This study was conducted on patients admitted to
Theodore Bilharz Research Institute after approval of
the institutional ethical committee and obtaining an
informed consent from every patient.
Results
The SDS-PAGE analysis and Coomassie brilliant blue
staining of F. gigantica E SA g sa r es h o w ni nF i g u r e1 .
The fractionated ES Ags containing several bands ran-
ged from 14 to 100 kDs.
Sensitivity, Specificity and Characterization of MoAbs
From a panel of MoAbs raised against F. gigantica ES
products, a pair (12B/11D/3F and 10A/9D/10G) was
selected due to their high reactivity to F. gigantica anti-
gen by indirect ELISA. Both MoAbs showed no cross-
reactions with S. mansoni, S. hematobium or H. nana
antigens. Isotypic analysis of the 12B/11D/3F and 10A/
9D/10G MoAbs revealed that they were of IgG1 and
IgG2 subclasses, respectively. The enzyme-linked immu-
noelectrotransfer blot (EITB) technique revealed that
the two selected MoAbs recognized 83, 64, 45 and 26
kDa bands of electrophorsed ES Ag (Figure 2). The che-
mical nature of MoAbs-recognized epitopes was defined
following 20 mM sodium periodate treatment of target
antigen. Marked reduction in MoAbs’ reactivity was
detected (Table 1), denoting that the reactive epitopes
were glycoprotein in nature.
MoAb-Sandwich ELISA
From the standard curve, the lower detection limit of
ELISA assay was 3 ng/ml. The cut- off value was
Figure 1 Fasciola ES antigens resolved from SDS-PAGE and
stained by Coomassie brilliant blue 0.05%. Lane 1: High
molecular weight standard. Lanes 2, 3, 4: Fasciola ES antigens from
three different cultures.
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+ 2 standard deviation of the mean. The OD readings
equal to or less than cut- off value were considered
negative while those readings greater than the cut off
v a l u ew e r ec o n s i d e r e dp o s i t i v e .T h es p e c i f i c i t yo ft h e
assay was determined as the sum of results of negative
control group and other parasites group.
In serum, the cut-off value was 0.263 and ES Ag was
detected in 47 out of 50 Fasciola-infected patients and
the sensitivity of the assay was 94% while in stool elutes
the cut-off value was 0.294 and 48 out of 50 Fasciola-
infected patients were positive, yielding a sensitivity of
96%. All the 20 negative controls had ES Ag levels
below the cut-off value in both serum and stool sam-
ples. Furthermore, 32 out of 35 serum samples and 34
out of 35 stool elutes belonging to patients harboring
other parasites had undetectable ES Ag of Fasciola lead-
ing to overall specificity 94.6% (52/55) and 98.2% (54/
55) in serum and stool samples, respectively. The diag-
nostic efficacy of the assay was 94.3% and 97.1%, respec-
tively (Figures 3, 4).
A positive correlation was found between ova count in
stools of Fasciola-infected patients and the OD readings
of ELISA in both stool and serum samples (r =0 . 7 3 0 ,p
< 0.001 and r = 0.608; p < 0.001, respectively).
Discussion
In this study, a MoAb-based sandwich ELISA was
employed for detection of circulating F. gigantica ES
Ags in both serum and stool samples of F. gigantica
infected patients. Identification of the target antigens
recognized by anti-Fasciola MoAbs (12B/11D/3F and
10A/9D/10D) showed that they were glycoproteins and
their MW lay in the 83, 64, 45 and 26 kDa regions.
Close to our findings, Arafa et al. [30] produced mono-
specific antibodies against ES Ags of F. gigantica whose
target antigens were recognized at 27.5, 32.5 and 55 kDa
regions. They reported that cross reactivity with Schisto-
soma mansoni occurs at higher MW (110-120 kDa).
In the present study, our MoAbs were able to detect
F. gigantica antigens level ≥ 3 ng/ml in sandwich ELISA.
This could be attributed to the use of a pair of MoAbs,
one as antigen capturing antibody (12B/11D/3F) which
enhance the binding capacity of the other MoAb (10A/
9D/10G) to the ES Ags that could help to reduce back-
ground and led to lowering the detection limit of these
MoAbs. This detection limit is lower than those of
Espino and Finlay [11] who detected Fasciola ES Ags in
patients’ stool at a concentration > 15 ng/ml. Also,
Anuracpreeda et al. [31] developed a MoAb-based sand-
wich ELISA for detection of 28.5 kDa tegumental anti-
gen (TA) in sera of mice experimentally infected with F.
gigantica and found that the lower detection limit was
60 ng/ml for SE antigens, 16 ng/ml for whole body anti-
gen, and 600 pg/ml for 28.5 kDa TA.
In the present study, the sensitivity and specificity of
MoAb-based ELISA in serum was 94% and 95.6%, while
in stool samples it was 96% and 98.2%, respectively. A
few antigen detection assays have been developed for
diagnosis of F. gigantica in human fluids with varied
ranges of sensitivities and specificities [11,18,30]. The
difference in specificities could be attributed to the com-
plex composition of ES that makes this antigenic pre-
paration not amenable to compare its performance in
ELISA results reported from different groups. This may
be due to the different protocols used to prepare ES
[32-34] or to the variation in its composition when
obtained from parasites derived from different hosts
[35], which is not the case when a purified antigen is
used [36].
In this study, the diagnostic efficacy of MoAb-based
sandwich ELISA in stool (coproantigens) was superior
to serum samples (97.1% vs 94.3%); this could be due to
the fact that coproantigens offered several advantages, e.
g., the levels of coproantigens are less affected by
immune complex formation than circulating Fasciola
antigens, coproantigens are detectable during prepatent
and patent phases of infection, non-invasive and finally
the nature of these antigens of being glycoprotein mak-
ing the coproantigen stable under several different sto-
rage conditions which ensured its diagnostic value
[11,18,31,37,38].
A positive correlation was found between ova count/
gm stool of Fasciola infected patients and the OD
Figure 2 Enzyme-linked immunoelectrotransfer blot of purified
Fasciola ES antigen resolved on 12.5% SDS-PAGE and probed
with a pair of MoAbs against ES products. Lane 1: Low
molecular weight standard. Lane 2: The 10A/9D/10G MoAb. Lane 3:
The 12B/11D/3F MoAb.
Table 1 Impact of ES antigen treatment with 20 mM
sodium periodate on MoAbs’ reactivity by indirect ELISA
(OD = 492 nm)
Target MoAbs Before treatment After treatment % Reduction
12B/11D/3F 1.50 ± 0.15 0.71 ± 0.12 52.7%
10A/9D/10G 1.35 ± 0.12 0.56 ± 0.09 58.5%
Data are expressed as mean ± standard deviation or percent.
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reading at 492 nm). The horizontal line represents the cut-off value of the assay (the lower detection limit). Dotted lines represent the mean
OD value.
Figure 4 Level of Fasciola ES antigen detected in stool samples of different studied groups measured by sandwich ELISA (OD reading
at 492 nm). The horizontal line represents the cut-off value of the assay (the lower detection limit). Dotted lines represent the mean OD value.
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Other studies have demonstrated that coproantigens are
correlated with Fasciola egg counts [11] and the parasite
burden [31,39,40]. As the fecal egg count is presumably
dependent on the number of flukes in the host, one can
postulate that stool antigen level in patients infected
with Fasciola are directly related to the number of adult
parasites. Therefore, the absence of coproantigen in one
of our patients may be due to a very light parasite bur-
den and consequently undetectable levels of antigens in
stools [14,18]. On the other hand, Ubeira et al. [32]
reported that there was no correlation between number
of ova/gm stool and coproantigens levels measured by
ELISA.
Conclusion
Our results provide evidence that detection of ES anti-
gens in stool specimens improves and simplifies the
diagnosis of F. gigantica infection in human. By using
this assay, the presence of ES Ags was easily demon-
strated in most of the stool specimens from patients
with confirmed F. gigantica presenting a reliable, non-
invasive diagnostic method for active infection.
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